$レナリティクスAI(RNLX.US)$Renalytix Announces That KidneyIntelX In-vitro Diagnostic Test Has Been Included In Final KDIGO (Kidney Disease Improving Global Outcomes) 2024 Clinical Practice Guideline For The Evaluation And Management Of Chronic Kidney Disease